Tumor markers in cancer diagnosis and prognosis
Full article: Tumor markers in clinical practice: General principles and guidelines
Tumor Marker - an overview | ScienceDirect Topics
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
CISN - The Promise of Tumor Markers
Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers | Semantic Scholar
A Bad Tumor Marker Test Is as Bad as a Bad Drug: The Case for More Consistent Regulation of Cancer Diagnostics | ASCO Connection
Computational advances of tumor marker selection and sample classification in cancer proteomics - ScienceDirect
Cancer Association of South Africa (CANSA)
107/12/13「Tumor markers of malignancies」 by ksdoctor - Issuu
Cancers | Free Full-Text | Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know | HTML
PDF) Chapter 4 CLINICAL USE OF TUMOR MARKERS
What are cancer markers? - Quora
Tumor markers in cancer diagnosis and prognosis
PDF) Chapter 4 CLINICAL USE OF TUMOR MARKERS
Development of techniques for the early detection of cancer by blood test
Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
Frontiers | The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer | SpringerLink
Biomarkers in molecular medicine: cancer detection and diagnosis | BioTechniques
Role of tumour markers in clinical practice
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology
State-of-the-Art Management of Germ Cell Tumors | American Society of Clinical Oncology Educational Book
Biomarker assessment and molecular testing for prognostication in breast cancer - Kos - 2016 - Histopathology - Wiley Online Library
![PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e977c065bbeedc4ec3317993fa3477329dffa910/4-TableI-1.png "PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar")
PDF] Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls | Semantic Scholar
Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles - ScienceDirect
Tumor Marker - an overview | ScienceDirect Topics
